RT @ericdeinmd: #RNL2023 Year in Review New Drugs in Old Disease? GCA - Tocilizumab (GiACTA ), Secikinumab (TitAIN), Mav
Tweet Content
#RNL2023 Year in Review
New Drugs in Old Disease?
GCA - Tocilizumab (GiACTA ), Secikinumab (TitAIN), Mavrilimumab (GM-CSFr mAb)
PMR - Sarilumab (SAPHYR), TCZ (PMR-Spare, SEMAPHORE), Tofacitinib (EAST PMR)
@RheumNow https://t.co/cY2HuaI6uM
Show on Archive Page
On
Display in Search Results
On
PDQ
Off